Daniel E. Weiner, MD, a nephrologist at Tufts Medical Center and associate professor of medicine at Tufts University School of Medicine in Boston, Massachusetts, received the National Kidney Foundation’s top research award at the 2022 Spring Clinical Meetings.
Creatinine alone does not reliably predict renal decline in the AKPKD population, according to investigators.
Patients with vs without chronic kidney disease have 32% lower odds of undergoing invasive cardiac procedures for acute coronary syndrome in adjusted analyses.
Hyper- and hyponatremia in patients with kidney failure are significantly associated with a 2.0- and 1.8-fold increased risk of dying in the hospital, respectively.
The federal Comprehensive ESRD Care initiative “may incentivize treatment patterns that generate short-term savings but may be costlier long-term,” according to investigators.
Nearly 24% of patients with advanced CKD, including those on dialysis, have gout, according to a study.
Policy-level interventions targeting underserved populations are necessary to improve their access to care.
Investigators report sustained reductions in urinary and plasma oxalate through 24 months of lumasiran treatment.
In a study of patients with CKD and/or heart failure on RAASi therapy, the proportion of patients who received dose reductions or had therapy discontinued after new-onset hyperkalemia increased with hyperkalemia severity.
Nearly two-thirds of patients receiving dialysis use phosphate binders intermittently, a study found.
Two-thirds of studied patients were exposed to nephrotoxic medications, which was identified as a risk factor for RRT initiation.
Hypercalcemia was common among kidney transplant recipients at 3 months, investigators reported.
Kidney stone risk factors and composition vary according to renal function in patients with chronic kidney disease.
Hospital length of stay, however, is significantly longer for women than men.
Investigators sought to distinguish the underlying cause of hyperkalemia after solid organ transplantation, whether from medications or organ dysfunction.
The mechanism by which pre-transplant hypernatremia leads to post-transplant mortality is currently unclear.
The “Advancing American Kidney Health Initiative” aims to reduce the ESRD rate by 25% by 2030.